Mark J. Holterman, Medical

NIH Medical Scientist Training Program Funds Biomedical Research

 

MSTP pic
MSTP
Image: nih.gov

A professor of surgery and pediatrics at the University of Illinois College of Medicine, Dr. Mark Holterman formerly served as an attending pediatric surgeon at Rush University Medical Center and as the surgeon-in-chief at Advocate Children’s Hospital. Mark Holterman, MD, started his medical career at the University of Virginia in the National Institutes of Health Medical Scientist Training Program (MSTP).

Funded through the Ruth L. Kirschstein Grant, the MSTP program supports the training of qualified students who are seeking dual doctorates (MD and PhD) and are motivated to pursue biomedical research and other research-related careers in academia, industry, and government. Benefitting from an education that integrates biomedical sciences with clinical training, 900 trainees at 48 sites are funded through the MSTP program.

Students can choose research projects in a wide array of specialties, including biology, chemistry, behavioral science, and computer science. Those who prevail in the highly competitive grant selection process typically spend eight years obtaining their dual degrees. MSTP grant winners receive a stipend and tuition allowance.

Advertisements
Mark J. Holterman, Medical

ADA Praises Congress for Funding Special Diabetes Program

 

Research Awards pic
American Diabetes Association
Image: professional.diabetes.org

With three decades of experience as a physician and an educator, Mark Holterman, MD, serves as a professor of medicine at the University of Illinois College of Medicine. In addition to his work as an educator, Dr. Mark Holterman engages with such organizations as the American Diabetes Association (ADA).

The ADA recently praised the federal government for agreeing to fund the Special Diabetes Program (SDP) to the tune of $600 million. SDP is one of the major drivers of research into type 1 diabetes and how to prevent type 2 diabetes for American Indians across the country. Thanks to this new funding, researchers will be able to continue exploring new treatments for diabetes in these communities, which are at exceptionally high risk of developing the disease.

The ADA recognized the Diabetes Caucuses in both houses of Congress for their work in helping this funding package come to fruition. The organization says it will continue to work with lawmakers to ensure that programs such as SDP continue to receive the support they need.

Mark J. Holterman, Medical

Study – Enhanced Recovery Plan for Colorectal Surgical Patients

 

Dr. Mark J. Holterman pic
Dr. Mark J. Holterman
Image: osfhealthcare.org

Mark Holterman, MD, serves as a professor of surgery and pediatrics at the University of Illinois College of Medicine in Peoria. Dr. Mark Holterman also is a fellow of the American College of Surgeons.

According to a recent study published by the American College of Surgeons, a new procedure for handling patient care through every stage of colorectal surgery not only helps these individuals have better outcomes, but also reduces the amount of time they have to stay in the hospital after surgery and results in lowered opioid pain medication usage.

In their study, researchers found that this new enhanced recovery program reduced hospital stays by an average of two days. Patients also were 14 percent less likely to develop abnormal bowel function and required 500-plus fewer units of morphine to manage their pain. The study’s lead author, Ian Paquette, MD, FACS, touted the results as a major breakthrough for surgeons and patients looking for better ways to handle recovery.

Mark J. Holterman, Medical

AACA Looks at Parametric Human

 

American Association of Clinical Anatomists  pic
American Association of Clinical Anatomists
Image: clinical-anatomy.org

A board-certified pediatric surgeon, Mark Holterman, MD, serves as a professor of surgery and pediatrics at the University of Illinois College of Medicine in Peoria. Active in the medical field outside of his work, Dr. Mark Holterman is a member of the American Association of Clinical Anatomists (AACA).

The AACA recently highlighted the work of a multidisciplinary team of doctors and data scientists that could fundamentally shift the way we doctors tailor individualized medical treatment. Dubbed the parametric human, researchers are close to developing a completely 3D-printable “virtual” human that can be customized with all the different musculoskeletal variations currently known.

Doctors would then be able to run diagnostic tests on this virtual human to potentially see how it can respond to certain types of treatment, eliminating the need for animal testing altogether. The group behind the project says the goal is to become intimately familiar with the human body, beyond the superficial diagrams and other data that is so often used in anatomical education.

Mark J. Holterman, Medical

About PAPS Membership

 

Pacific Association of Pediatric Surgeons pic
Pacific Association of Pediatric Surgeons
Image: pacificassociationofpediatricsurgeons.org

A longtime proponent of stem cell research and therapy, Mark Holterman, MD, serves as pediatrics professor at the University of Illinois College of Medicine in Peoria. Alongside his work, Dr. Mark Holterman belongs to the Pacific Association of Pediatric Surgeons (PAPS).

PAPS is an exclusive organization aimed at promoting fellowship and education among doctors who are from Pacific Rim nations. The organization currently has more than 500 members spanning 23 countries. Surgeons who spend more than 90 percent of their time in pediatric care are eligible to join the organization through geography and by invitation.

Potential applicants must either currently be practicing pediatric surgery in a Pacific-bordering country. If that surgeon moves away from the Pacific area, they can remain in the organizations by attending at least three PAPS meetings within the last decade. They must also be practicing pediatric surgeons for at least a year before becoming eligible to apply for membership.

Mark J. Holterman, Medical

American Diabetes Association Issues Joint Guidance on CGMs

 

American Diabetes Association pic
American Diabetes Association
Image: diabetes.org

Possessing decades of experience as both a physician and an educator, Mark Holterman, MD, serves as a professor of medicine at the University of Illinois College of Medicine. In addition to his work educating students, Dr. Mark Holterman is a longtime supporter of the American Diabetes Association.

Continuous glucose monitoring (CGM) systems provide people with diabetes real-time feedback about changes in their blood sugar levels. This helps them decide whether or not to eat different things or integrate some exercise into their daily routines. Even though these devices offer significant benefits to patients, they are not used as much as they could be, because a lack of standardized guidelines exist on how they should be prescribed. That’s why the American Diabetes Association has partnered with the European Association for the Study of Diabetes to issue a joint statement called “Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations.”

The new statement provides recommendations on marketing, clinical data reporting, and regulatory guidance, among other items. It can be found in the December 2017 edition of Diabetes Care and is based on a comprehensive examination of 50-plus scientific articles about CGMs.

Mark J. Holterman, Medical

The Potential of Regenerative Medicine to Restore Organ Function

 

Dr. Mark J. Holterman pic
Dr. Mark J. Holterman
Image: osfhealthcare.org

Dr. Mark Holterman, a longtime advocate of regenerative medicine and stem cell therapy, serves as pediatrics professor at the University of Illinois College of Medicine in Peoria. Reflecting decades of research employing ethically sourced fetal stem cells, Mark J. Holterman, MD, seeks to promote the academic study of the safety and efficacy of innovative treatment modalities.

An emerging area of medical science, regenerative medicine at its foundation centers on restoring the functionality of organs and tissues, specifically those that have been damaged or are associated with chronic disease and severe injuries that do not respond to conventional therapies. Restoration of function is enabled through a combination of tissue engineering and gene editing advancements, which allows stem cells to be remodeled as three-dimensional tissue structures and organoids that meet highly specific needs.

Enabling this is the potentially limitless ability of stem cells to divide and transdifferentiate into a variety of cell types. As such, stem cells provide a foundation for the body’s full range of organs and tissues. Employing microengineering and cell transplantation techniques, organoids are grown that have the potential to take the place of donated organs and tissues, which are of limited supply and expensive.